Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial

Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The page footer/UI now reflects a newer site build revision (v3.5.3 instead of v3.5.2) without changing the displayed clinical trial history details.
    Difference
    0.1%
    Check dated 2026-04-26T08:10:19.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    Added revision v3.5.2 to the study record history and removed revision v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-19T01:19:13.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Record history shows revision v3.5.0 added and revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-21T08:43:20.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    The history now includes revision v3.4.3, while revision v3.4.2 is removed.
    Difference
    0.1%
    Check dated 2026-03-06T19:02:42.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    A new revision v3.4.2 is added to the study history, and the previous revision v3.4.1 is removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:21:30.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The revision history now reflects the addition of v3.4.1 and the removal of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-05T23:29:27.000Z thumbnail image

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.